The glaucoma drainage devices market size has grown strongly in recent years. It will grow from $0.89 billion in 2025 to $0.98 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to increasing prevalence of glaucoma, expansion of ophthalmic surgical centers, growing adoption of surgical glaucoma treatments, rising aging population, availability of specialized eye care facilities.
The glaucoma drainage devices market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive eye surgeries, rising investments in ophthalmic device innovation, expansion of advanced glaucoma care programs, growing focus on early intervention, technological advancements in implant materials and design. Major trends in the forecast period include increasing adoption of minimally invasive glaucoma implants, rising demand for valved drainage devices, growing focus on long-term intraocular pressure control, expansion of advanced biocompatible materials, enhanced precision in surgical implant design.
The rising prevalence of glaucoma is expected to drive the growth of the glaucoma drainage devices market in the coming years. Glaucoma refers to a group of eye disorders that damage the optic nerve, often due to elevated intraocular pressure, which can lead to vision loss if left untreated. The increase in glaucoma cases is driven by factors such as an aging population, urbanization, and lifestyle changes. Glaucoma drainage devices assist in managing intraocular pressure in refractory glaucoma by facilitating aqueous humor outflow when conventional treatments are insufficient. For example, in October 2025, the NHS Confederation, a UK-based membership organization, reported that glaucoma - the leading cause of irreversible sight loss in the UK - affects over 700,000 people, nearly half of whom remain undiagnosed due to its asymptomatic nature and long hospital waits. NHS waiting times can reach up to 72 weeks, and major eye conditions are projected to increase by 25% from 2022 to 2032, outpacing population growth sevenfold. Therefore, the increasing prevalence of glaucoma is driving growth in the glaucoma drainage devices market.
The expansion of healthcare infrastructure is expected to drive the growth of the glaucoma drainage devices market in the coming years. Healthcare infrastructure encompasses the network of hospitals, clinics, diagnostic centers, and supporting medical facilities that provide populations with access to quality healthcare services. This expansion is fueled by increasing government and private sector investments, a growing population, and rising demand for advanced medical care. Enhanced infrastructure facilitates the adoption of new medical technologies, improves patient access, and increases the efficiency of healthcare delivery. For example, in May 2023, a report from the Office for National Statistics, a UK-based government department, noted that healthcare spending in the UK rose by 5.6% between 2022 and 2023, compared with 0.9% growth in 2022, with total healthcare expenditure reaching approximately $317.63 billion (£292 billion) in 2023. Therefore, the expansion of healthcare infrastructure is driving growth in the glaucoma drainage devices market.
Leading companies in the glaucoma drainage devices market are focusing on developing advanced canal-based surgical devices to provide minimally invasive treatment options and meet the rising demand for safer and more effective therapies. Canal-based glaucoma surgery devices are implants that target the Schlemm's canal to improve aqueous humor drainage, thereby lowering intraocular pressure (IOP). This helps manage glaucoma by addressing the root cause of the disease's progression. For example, in March 2023, Nova Eye Medical Limited, an Australian manufacturer of glaucoma devices, obtained clearance for its iTrack Advance canaloplasty device. This cutting-edge device is designed for microcatheterization and viscodilation to reduce IOP in adult patients with primary open-angle glaucoma. The iTrack Advance features an ergonomic handpiece and advanced technology to enhance surgical efficiency, and it is suitable for both standalone procedures and those performed alongside cataract surgery.
Major companies operating in the glaucoma drainage devices market are AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., Rheon-medical.
North America was the largest region in the glaucoma drainage devices market in 2025. The regions covered in the glaucoma drainage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the glaucoma drainage devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the glaucoma drainage devices market by increasing costs of imported medical-grade polymers, nitinol components, precision molding equipment, and sterilization materials used in implant manufacturing. Ophthalmology centers in North America and Europe are most affected due to dependence on imported high-quality implants, while Asia-Pacific faces increased export manufacturing costs. These tariffs are raising device prices and affecting hospital procurement budgets. However, they are also encouraging domestic production, regional material sourcing, and investment in local ophthalmic device manufacturing capabilities.
The glaucoma drainage devices market research report is one of a series of new reports that provides glaucoma drainage devices market statistics, including glaucoma drainage devices industry global market size, regional shares, competitors with a glaucoma drainage devices market share, detailed glaucoma drainage devices market segments, market trends and opportunities, and any further data you may need to thrive in the glaucoma drainage devices industry. This glaucoma drainage devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Glaucoma drainage devices are surgical implants designed to lower intraocular pressure in patients with glaucoma. These devices facilitate controlled outflow of aqueous humor from the eye, helping to prevent optic nerve damage. They are typically used when other treatments, such as medications or laser therapy, are not effective.
The primary types of glaucoma drainage devices are valved and non-valved glaucoma drainage devices. Valved glaucoma drainage devices are implantable devices that feature a one-way valve, which regulates the flow of aqueous humor to reduce intraocular pressure (IOP) in patients with refractory glaucoma. These devices help minimize the risk of hypotony. They are used in various types of surgeries, including conventional glaucoma surgery and minimally invasive glaucoma surgery, and are utilized by end users such as hospitals, specialty clinics, ambulatory surgical centers, and other healthcare settings.
The glaucoma drainage devices market consists of sales of glaucoma valves, drainage tubes, and associated medical accessories or tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The glaucoma drainage devices market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive eye surgeries, rising investments in ophthalmic device innovation, expansion of advanced glaucoma care programs, growing focus on early intervention, technological advancements in implant materials and design. Major trends in the forecast period include increasing adoption of minimally invasive glaucoma implants, rising demand for valved drainage devices, growing focus on long-term intraocular pressure control, expansion of advanced biocompatible materials, enhanced precision in surgical implant design.
The rising prevalence of glaucoma is expected to drive the growth of the glaucoma drainage devices market in the coming years. Glaucoma refers to a group of eye disorders that damage the optic nerve, often due to elevated intraocular pressure, which can lead to vision loss if left untreated. The increase in glaucoma cases is driven by factors such as an aging population, urbanization, and lifestyle changes. Glaucoma drainage devices assist in managing intraocular pressure in refractory glaucoma by facilitating aqueous humor outflow when conventional treatments are insufficient. For example, in October 2025, the NHS Confederation, a UK-based membership organization, reported that glaucoma - the leading cause of irreversible sight loss in the UK - affects over 700,000 people, nearly half of whom remain undiagnosed due to its asymptomatic nature and long hospital waits. NHS waiting times can reach up to 72 weeks, and major eye conditions are projected to increase by 25% from 2022 to 2032, outpacing population growth sevenfold. Therefore, the increasing prevalence of glaucoma is driving growth in the glaucoma drainage devices market.
The expansion of healthcare infrastructure is expected to drive the growth of the glaucoma drainage devices market in the coming years. Healthcare infrastructure encompasses the network of hospitals, clinics, diagnostic centers, and supporting medical facilities that provide populations with access to quality healthcare services. This expansion is fueled by increasing government and private sector investments, a growing population, and rising demand for advanced medical care. Enhanced infrastructure facilitates the adoption of new medical technologies, improves patient access, and increases the efficiency of healthcare delivery. For example, in May 2023, a report from the Office for National Statistics, a UK-based government department, noted that healthcare spending in the UK rose by 5.6% between 2022 and 2023, compared with 0.9% growth in 2022, with total healthcare expenditure reaching approximately $317.63 billion (£292 billion) in 2023. Therefore, the expansion of healthcare infrastructure is driving growth in the glaucoma drainage devices market.
Leading companies in the glaucoma drainage devices market are focusing on developing advanced canal-based surgical devices to provide minimally invasive treatment options and meet the rising demand for safer and more effective therapies. Canal-based glaucoma surgery devices are implants that target the Schlemm's canal to improve aqueous humor drainage, thereby lowering intraocular pressure (IOP). This helps manage glaucoma by addressing the root cause of the disease's progression. For example, in March 2023, Nova Eye Medical Limited, an Australian manufacturer of glaucoma devices, obtained clearance for its iTrack Advance canaloplasty device. This cutting-edge device is designed for microcatheterization and viscodilation to reduce IOP in adult patients with primary open-angle glaucoma. The iTrack Advance features an ergonomic handpiece and advanced technology to enhance surgical efficiency, and it is suitable for both standalone procedures and those performed alongside cataract surgery.
Major companies operating in the glaucoma drainage devices market are AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., Rheon-medical.
North America was the largest region in the glaucoma drainage devices market in 2025. The regions covered in the glaucoma drainage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the glaucoma drainage devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the glaucoma drainage devices market by increasing costs of imported medical-grade polymers, nitinol components, precision molding equipment, and sterilization materials used in implant manufacturing. Ophthalmology centers in North America and Europe are most affected due to dependence on imported high-quality implants, while Asia-Pacific faces increased export manufacturing costs. These tariffs are raising device prices and affecting hospital procurement budgets. However, they are also encouraging domestic production, regional material sourcing, and investment in local ophthalmic device manufacturing capabilities.
The glaucoma drainage devices market research report is one of a series of new reports that provides glaucoma drainage devices market statistics, including glaucoma drainage devices industry global market size, regional shares, competitors with a glaucoma drainage devices market share, detailed glaucoma drainage devices market segments, market trends and opportunities, and any further data you may need to thrive in the glaucoma drainage devices industry. This glaucoma drainage devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Glaucoma drainage devices are surgical implants designed to lower intraocular pressure in patients with glaucoma. These devices facilitate controlled outflow of aqueous humor from the eye, helping to prevent optic nerve damage. They are typically used when other treatments, such as medications or laser therapy, are not effective.
The primary types of glaucoma drainage devices are valved and non-valved glaucoma drainage devices. Valved glaucoma drainage devices are implantable devices that feature a one-way valve, which regulates the flow of aqueous humor to reduce intraocular pressure (IOP) in patients with refractory glaucoma. These devices help minimize the risk of hypotony. They are used in various types of surgeries, including conventional glaucoma surgery and minimally invasive glaucoma surgery, and are utilized by end users such as hospitals, specialty clinics, ambulatory surgical centers, and other healthcare settings.
The glaucoma drainage devices market consists of sales of glaucoma valves, drainage tubes, and associated medical accessories or tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Glaucoma Drainage Devices Market Characteristics
3. Glaucoma Drainage Devices Market Supply Chain Analysis
4. Global Glaucoma Drainage Devices Market Trends and Strategies
5. Glaucoma Drainage Devices Market Analysis of End Use Industries
7. Global Glaucoma Drainage Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Glaucoma Drainage Devices Total Addressable Market (TAM) Analysis for the Market
9. Glaucoma Drainage Devices Market Segmentation
10. Glaucoma Drainage Devices Market Regional and Country Analysis
11. Asia-Pacific Glaucoma Drainage Devices Market
12. China Glaucoma Drainage Devices Market
13. India Glaucoma Drainage Devices Market
14. Japan Glaucoma Drainage Devices Market
15. Australia Glaucoma Drainage Devices Market
16. Indonesia Glaucoma Drainage Devices Market
17. South Korea Glaucoma Drainage Devices Market
18. Taiwan Glaucoma Drainage Devices Market
19. South East Asia Glaucoma Drainage Devices Market
20. Western Europe Glaucoma Drainage Devices Market
21. UK Glaucoma Drainage Devices Market
22. Germany Glaucoma Drainage Devices Market
23. France Glaucoma Drainage Devices Market
24. Italy Glaucoma Drainage Devices Market
25. Spain Glaucoma Drainage Devices Market
26. Eastern Europe Glaucoma Drainage Devices Market
27. Russia Glaucoma Drainage Devices Market
28. North America Glaucoma Drainage Devices Market
29. USA Glaucoma Drainage Devices Market
30. Canada Glaucoma Drainage Devices Market
31. South America Glaucoma Drainage Devices Market
32. Brazil Glaucoma Drainage Devices Market
33. Middle East Glaucoma Drainage Devices Market
34. Africa Glaucoma Drainage Devices Market
36. Glaucoma Drainage Devices Market Competitive Landscape and Company Profiles
37. Glaucoma Drainage Devices Market Other Major and Innovative Companies
40. Glaucoma Drainage Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Glaucoma Drainage Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses glaucoma drainage devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for glaucoma drainage devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The glaucoma drainage devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Valved Glaucoma Drainage Devices; Non-Valved Glaucoma Drainage Devices2) By Surgery Type: Conventional Glaucoma Surgery; Minimally Invasive Glaucoma Surgery
3) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Valved Glaucoma Drainage Devices: Ahmed Glaucoma Valve; Baerveldt Glaucoma Implant; Krupin Implant; Others2) By Non-Valved Glaucoma Drainage Devices: Molteno Implant; Schocket Implant; Foster Implant; Others
Companies Mentioned: AbbVie Inc.; Alcon Inc.; Johnson And Johnson Vision Care Inc.; Santen Pharmaceutical Co. Ltd.; Glaukos Corporation; Ocular Therapeutix Inc.; IRIDEX Corporation; New World Medical Inc.; Ivantis Inc.; iSTAR Medical; Nova Eye Medical Limited; Altomed; Aurolab; G.surgiwear Limited; Eagle Vision Inc.; Advanced Ophthalmic Innovations Pte Ltd.; Avisi Technologies Inc.; iVeena Delivery Systems; Optonol Ltd.; Rheon-medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Glaucoma Drainage Devices market report include:- AbbVie Inc.
- Alcon Inc.
- Johnson And Johnson Vision Care Inc.
- Santen Pharmaceutical Co. Ltd.
- Glaukos Corporation
- Ocular Therapeutix Inc.
- IRIDEX Corporation
- New World Medical Inc.
- Ivantis Inc.
- iSTAR Medical
- Nova Eye Medical Limited
- Altomed
- Aurolab
- G.surgiwear Limited
- Eagle Vision Inc.
- Advanced Ophthalmic Innovations Pte Ltd.
- Avisi Technologies Inc.
- iVeena Delivery Systems
- Optonol Ltd.
- Rheon-medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.98 Billion |
| Forecasted Market Value ( USD | $ 1.42 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
